How Oncologists and Pathologists Can Best Collaborate to Provide Precision Medicine for Their Patients

David Spigel, MD

Video Categories: 2018 ASCO Insights and Video Library

Dr David Spigel discusses how medical oncologists and the rest of the cancer care team can best communicate with pathologists to help make informed treatment decisions for individual patients and set up new assays for emerging biomarkers as they are discovered.

October 14, 2014

Treatment Approach with Hydoxyurea

Laura C. Michaelis, MD, Medical College of Wisconsin describes the approach of treating polycythemia vera with hydoxyurea.Supported through funding from Incyte

December 18, 2018

Reimbursement Challenges and Solutions with Molecular Biomarker Testing

Drs. Geoffrey Oxnard and Lauren Ritterhouse consider the current landscape of reimbursement for molecular biomarker testing, the need to run FDA-approved tests, and the role of CMS and local Medicare providers in testing reimbursement.